Articles

UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (35800) 35800
Newspaper Article (740) 740
Book / eBook (205) 205
Newsletter (125) 125
Magazine Article (111) 111
Conference Proceeding (51) 51
Web Resource (40) 40
Book Chapter (36) 36
Government Document (14) 14
Book Review (12) 12
Dissertation (9) 9
Journal / eJournal (8) 8
Trade Publication Article (8) 8
Publication (7) 7
Reference (2) 2
Report (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (29651) 29651
male (16087) 16087
female (15674) 15674
science & technology (15258) 15258
life sciences & biomedicine (14702) 14702
middle aged (11690) 11690
adult (9720) 9720
aged (8958) 8958
iodine radioisotopes - therapeutic use (8949) 8949
biological and medical sciences (7869) 7869
medical sciences (7362) 7362
animals (7360) 7360
radiology, nuclear medicine & medical imaging (5783) 5783
radiotherapy dosage (5376) 5376
radioisotopes (5194) 5194
oncology (4829) 4829
abridged index medicus (3689) 3689
treatment outcome (3622) 3622
brachytherapy (3356) 3356
mice (3333) 3333
radionuclide imaging (3255) 3255
follow-up studies (3110) 3110
radioisotopes - therapeutic use (3092) 3092
iodine radioisotopes (2999) 2999
brachytherapy - methods (2969) 2969
tumors (2863) 2863
radiotherapy (2798) 2798
cobalt radioisotopes - therapeutic use (2709) 2709
time factors (2697) 2697
adolescent (2665) 2665
nuclear medicine (2626) 2626
aged, 80 and over (2620) 2620
combined modality therapy (2609) 2609
retrospective studies (2606) 2606
cancer (2599) 2599
thyroid neoplasms - radiotherapy (2263) 2263
radioisotope teletherapy (2075) 2075
radiopharmaceuticals - therapeutic use (2040) 2040
radiology (1991) 1991
rats (1985) 1985
care and treatment (1966) 1966
prognosis (1923) 1923
medicine & public health (1918) 1918
tissue distribution (1911) 1911
patients (1896) 1896
pharmacology. drug treatments (1847) 1847
child (1846) 1846
radiation therapy (1735) 1735
prostatic neoplasms - radiotherapy (1705) 1705
medicine (1703) 1703
yttrium radioisotopes - therapeutic use (1701) 1701
thyroidectomy (1670) 1670
isotopes (1667) 1667
radiology and nuclear medicine (1630) 1630
radioisotope brachytherapy (1594) 1594
pharmacology & pharmacy (1507) 1507
radiopharmaceuticals (1490) 1490
carbon radioisotopes (1450) 1450
endocrinology & metabolism (1438) 1438
dosimetry (1425) 1425
antibodies, monoclonal - therapeutic use (1395) 1395
tomography, x-ray computed (1363) 1363
neoplasm staging (1362) 1362
surgery (1325) 1325
diseases (1317) 1317
thyroid neoplasms - pathology (1317) 1317
positron-emission tomography (1303) 1303
iodine radioisotopes - adverse effects (1276) 1276
therapy (1251) 1251
radioimmunotherapy (1231) 1231
prostate cancer (1220) 1220
neoplasms (1213) 1213
radiation dosage (1187) 1187
radiotherapy. instrumental treatment. physiotherapy. reeducation. rehabilitation, orthophony, crenotherapy. diet therapy and various other treatments (1180) 1180
thyroid neoplasms - surgery (1173) 1173
antineoplastic agents - therapeutic use (1166) 1166
iridium radioisotopes - therapeutic use (1154) 1154
health aspects (1153) 1153
research (1139) 1139
prospective studies (1133) 1133
cell line, tumor (1131) 1131
organs (1122) 1122
dose-response relationship, radiation (1117) 1117
methods (1108) 1108
imaging / radiology (1090) 1090
nuclei (1086) 1086
body (1067) 1067
mice, nude (1055) 1055
thyroid cancer (1046) 1046
beta decay radioisotopes (1042) 1042
survival rate (1041) 1041
iodine (1038) 1038
neoplasms - radiotherapy (1024) 1024
positron emission tomography (1018) 1018
medical imaging (1017) 1017
brachytherapy - adverse effects (1013) 1013
analysis (1001) 1001
risk factors (983) 983
positron-emission tomography - methods (968) 968
metastasis (958) 958
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (79) 79
Online Resources - Online (40) 40
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (14) 14
Collection Dvlpm't (Acquisitions) - Vendor file (9) 9
Collection Dvlpm't (Acquisitions) - Closed Orders (6) 6
Gerstein Science - Periodical Stacks (3) 3
UofT at Scarborough - Stacks (3) 3
Gerstein Science - Bindery (2) 2
Robarts - Stacks (2) 2
Chemistry (A D Allen) - Stacks (1) 1
Engineering & Comp. Sci. - Stacks (1) 1
Gerstein Science - Circulation Desk (1) 1
Scarborough Hospital - Hospital Department (1) 1
St. Michael's College (John M. Kelly) - 2nd Floor (1) 1
St. Michael's Hospital - Stacks (1) 1
UofT at Mississauga - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (32243) 32243
German (2000) 2000
French (891) 891
Russian (655) 655
Japanese (553) 553
Italian (461) 461
Spanish (350) 350
Polish (284) 284
Chinese (277) 277
Portuguese (102) 102
Czech (76) 76
Dutch (65) 65
Hungarian (58) 58
Danish (41) 41
Romanian (27) 27
Swedish (26) 26
Croatian (21) 21
Hebrew (19) 19
Finnish (14) 14
Bulgarian (13) 13
Norwegian (12) 12
Serbian (12) 12
Ukrainian (11) 11
Slovak (9) 9
Turkish (6) 6
Korean (3) 3
Lithuanian (3) 3
Afrikaans (2) 2
Arabic (2) 2
Greek (2) 2
Persian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Cancer biotherapy & radiopharmaceuticals
Cancer biotherapy & radiopharmaceuticals, ISSN 1557-8852, 1996
Chemotherapy
Journal
Details down arrow
2. Full Text Skeletal metastases and impact of anticancer and bone-targeted agents in patients with castration-resistant prostate cancer
by Vignani, Francesca and Bertaglia, Valentina and Buttigliero, Consuelo and Tucci, Marcello and Scagliotti, Giorgio V and Di Maio, Massimo
Cancer treatment reviews, ISSN 0305-7372, 2016, Volume 44, pp. 61 - 73
Hematology, Oncology and Palliative Medicine | Bone-targeted therapy | Bone metastasis | Chemotherapy | Skeletal related event | Castration resistant prostate cancer | New generation hormonal agents | Life Sciences & Biomedicine | Oncology | Science & Technology | Anilides - therapeutic use | Phenylthiohydantoin - therapeutic use | Humans | Bone Neoplasms - secondary | Male | Antineoplastic Agents - therapeutic use | Prostatic Neoplasms, Castration-Resistant - pathology | Denosumab - therapeutic use | Taxoids - therapeutic use | Diphosphonates - therapeutic use | Bone Neoplasms - drug therapy | Imidazoles - therapeutic use | Mitoxantrone - therapeutic use | Carcinoma - secondary | Pyridines - therapeutic use | Carcinoma - drug therapy | Radioisotopes - therapeutic use | Dasatinib - therapeutic use | Docetaxel | Androstenes - therapeutic use | Bone Density Conservation Agents - therapeutic use | Zoledronic Acid | Prostatic Neoplasms, Castration-Resistant - drug therapy | Radium - therapeutic use | Phenylthiohydantoin - analogs & derivatives | Care and treatment | Metastasis | Prostate cancer | Cancer | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text US Food and Drug Administration approval of drugs for the treatment of prostate cancer: a new era has begun
by D'Amico, Anthony V and D'Amico, Anthony V
Journal of clinical oncology, ISSN 0732-183X, 2014, Volume 32, Issue 4, pp. 362 - 364
Life Sciences & Biomedicine | Oncology | Science & Technology | Phenylthiohydantoin - therapeutic use | United States | Humans | Drugs, Investigational | Male | Antineoplastic Agents - therapeutic use | Drug Approval | Androstenols - therapeutic use | Oligopeptides - therapeutic use | Taxoids - therapeutic use | Diphosphonates - therapeutic use | Imidazoles - therapeutic use | Goserelin - therapeutic use | Mitoxantrone - therapeutic use | Prostatic Neoplasms - drug therapy | United States Food and Drug Administration | Antibodies, Monoclonal, Humanized - therapeutic use | Radioisotopes - therapeutic use | Docetaxel | Androstenes | Tissue Extracts - therapeutic use | Zoledronic Acid | Denosumab | Radium - therapeutic use | Phenylthiohydantoin - analogs & derivatives | Estramustine - therapeutic use | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. European journal of nuclear medicine and molecular imaging
European Association of Nuclear Medicine
European journal of nuclear medicine and molecular imaging, ISSN 1619-7070, 2001
Nuclear medicine | Diagnostic imaging
Journal
Details down arrow
5. Full Text Somatostatin receptor-based imaging and therapy of gastroenteropancreatic neuroendocrine tumors
by Kwekkeboom, Dik J and Kam, Boen L and van Essen, Martijn and Teunissen, Jaap J M and van Eijck, Casper H J and Valkema, Roelf and de Jong, Marion and de Herder, Wouter W and Krenning, Eric P
Endocrine-related cancer, ISSN 1351-0088, 3/2010, Volume 17, Issue 1, pp. R53 - R73
Review | Oncology | Endocrinology & Metabolism | Life Sciences & Biomedicine | Science & Technology | Humans | Digestive System Neoplasms - radiotherapy | Antineoplastic Agents - therapeutic use | Yttrium Radioisotopes - pharmacokinetics | Octreotide - pharmacokinetics | Digestive System Neoplasms - drug therapy | Gallium Radioisotopes - therapeutic use | Digestive System Neoplasms - diagnostic imaging | Neuroendocrine Tumors - diagnostic imaging | Receptors, Somatostatin - analysis | Organometallic Compounds - therapeutic use | Yttrium Radioisotopes - therapeutic use | Somatostatin - analogs & derivatives | Radiopharmaceuticals - pharmacokinetics | Octreotide - analogs & derivatives | Organometallic Compounds - pharmacokinetics | Treatment Outcome | Clinical Trials as Topic | Combined Modality Therapy | Indium Radioisotopes - pharmacokinetics | Positron-Emission Tomography - methods | Octreotide - therapeutic use | Somatostatin - pharmacokinetics | Peptides, Cyclic - pharmacokinetics | Neuroendocrine Tumors - radiotherapy | Animals | Organotechnetium Compounds - pharmacokinetics | Positron-Emission Tomography - standards | Receptors, Somatostatin - drug effects | Gallium Radioisotopes - pharmacokinetics | Neuroendocrine Tumors - drug therapy | Peptides, Cyclic - therapeutic use | Quality of Life | Indium Radioisotopes - therapeutic use | Somatostatin - therapeutic use | Radiopharmaceuticals - therapeutic use | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Treating Patients with Metastatic Castration Resistant Prostate Cancer: A Comprehensive Review of Available Therapies
by Crawford, E. David and Higano, Celestia S and Shore, Neal D and Hussain, Maha and Petrylak, Daniel P
The Journal of urology, ISSN 0022-5347, 2015, Volume 194, Issue 6, pp. 1537 - 1547
Urology | neoplasm metastasis | androgen antagonists | drug therapy | castration | prostatic neoplasms | Life Sciences & Biomedicine | Urology & Nephrology | Science & Technology | Phenylthiohydantoin - adverse effects | Phenylthiohydantoin - therapeutic use | Humans | Male | Antineoplastic Agents - therapeutic use | Prostatic Neoplasms, Castration-Resistant - pathology | Taxoids - therapeutic use | Neoplasm Metastasis - drug therapy | Antineoplastic Agents - adverse effects | Prostatic Neoplasms, Castration-Resistant - therapy | Taxoids - adverse effects | Radioisotopes - therapeutic use | Androstenes - adverse effects | Radioisotopes - adverse effects | Docetaxel | Tissue Extracts - adverse effects | Androstenes - therapeutic use | Survival Rate | Radium - adverse effects | Tissue Extracts - therapeutic use | Radium - therapeutic use | Disease Progression | Phenylthiohydantoin - analogs & derivatives | Orchiectomy | Taxoids - administration & dosage | Neoplasm Metastasis - pathology | Androgen Antagonists - therapeutic use | Prostatic Neoplasms, Castration-Resistant - mortality | Androgen Antagonists - adverse effects | Neoplasm Staging | Medical colleges | Care and treatment | Metastasis | Prostate cancer | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Immunotherapy of cancer in 2012
by Kirkwood, John M and Butterfield, Lisa H and Tarhini, Ahmad A and Zarour, Hassane and Kalinski, Pawel and Ferrone, Soldano
CA: a cancer journal for clinicians, ISSN 0007-9235, 09/2012, Volume 62, Issue 5, pp. 309 - 335
Life Sciences & Biomedicine | Oncology | Science & Technology | Immunotherapy - methods | Dendritic Cells - immunology | Humans | Dendritic Cells - physiology | Antibodies, Monoclonal - therapeutic use | Programmed Cell Death 1 Receptor - antagonists & inhibitors | Antineoplastic Agents - therapeutic use | Vascular Endothelial Growth Factor A - antagonists & inhibitors | Bevacizumab | Cancer Vaccines - therapeutic use | Neoplasms - therapy | Immunotherapy - trends | Angiogenesis Inhibitors - therapeutic use | Receptor, ErbB-2 - antagonists & inhibitors | Cetuximab | Yttrium Radioisotopes - therapeutic use | Gene Transfer Techniques | Histocompatibility Antigens - immunology | Antibodies, Monoclonal, Humanized - therapeutic use | Alemtuzumab | Vaccines, DNA - therapeutic use | alpha-Fetoproteins - therapeutic use | alpha-Fetoproteins - immunology | Neoplasms - immunology | Tumor Necrosis Factor Receptor Superfamily, Member 9 - antagonists & inhibitors | Receptor, Epidermal Growth Factor - antagonists & inhibitors | T-Lymphocytes - immunology | Genetic Vectors | Trastuzumab | Care and treatment | Usage | Research | Health aspects | Immunotherapy | Cancer | Immunology | Cancer therapies | Manipulation | Tumors | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights